Acetaminophen/Caffeine/Dihydroergotamine Mesylate/Metoclopramide Hydrochloride

对乙酰氨基酚/咖啡因/甲磺酸双氢麦角胺/盐酸甲氧氯普胺

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAcetaminophen/Caffeine/Dihydroergotamine Mesylate/Metoclopramide Hydrochloride
Drug Alias NameCefalium
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists +[6] 
TargetsCyclooxygenasesAdenosine A1 receptorAdenosine A2a receptor +[6] 
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsYes AcetaminophenCaffeineDihydroergotamine Mesylate (Shin Nippon Biomedical Laboratories)
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAche Laboratorios Farmaceuticos Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAche Laboratorios Farmaceuticos Sa
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A